Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Association between the recurrence period of acute kidney injury and mortality: a single-centre retrospective observational study in Japan.

Sako K, Furuichi K, Yamamura Y, Oshima M, Toyama T, Kaneko S, Wada T.

BMJ Open. 2019 Jun 16;9(6):e023259. doi: 10.1136/bmjopen-2018-023259.

2.

The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage.

Sakai N, Bain G, Furuichi K, Iwata Y, Nakamura M, Hara A, Kitajima S, Sagara A, Miyake T, Toyama T, Sato K, Nakagawa S, Shimizu M, Kaneko S, Wada T.

Sci Rep. 2019 May 15;9(1):7414. doi: 10.1038/s41598-019-43576-x.

3.

A case of secondary IgA nephropathy accompanied by psoriasis treated with secukinumab.

Ochi M, Toyama T, Ando M, Sato K, Kamikawa Y, Sagara A, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Furuichi K, Hamaguchi Y, Kaneko S, Wada T.

CEN Case Rep. 2019 Apr 3. doi: 10.1007/s13730-019-00393-5. [Epub ahead of print]

4.

Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.

Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development.

Diabetes Care. 2019 May;42(5):891-902. doi: 10.2337/dc18-1320. Epub 2019 Mar 4.

PMID:
30833372
5.

[A Case of Encapsulated Peritoneal Sclerosis Associated with a Ventriculo-Peritoneal Shunt].

Kono K, Wada E, Nishioka T, Kinuta Y, Mizukami Y, Furuichi K, Sato S.

No Shinkei Geka. 2019 Feb;47(2):211-216. doi: 10.11477/mf.1436203919. Japanese.

PMID:
30818278
6.

Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive Nephrosclerosis.

Kohagura K, Furuichi K, Kochi M, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Am J Hypertens. 2019 Apr 22;32(5):486-491. doi: 10.1093/ajh/hpz010.

PMID:
30689693
7.

Evaluation of renal oxygen saturation using photoacoustic imaging for the early prediction of chronic renal function in a model of ischemia-induced acute kidney injury.

Okumura K, Matsumoto J, Iwata Y, Yoshida K, Yoneda N, Ogi T, Kitao A, Kozaka K, Koda W, Kobayashi S, Inoue D, Sakai N, Furuichi K, Wada T, Gabata T.

PLoS One. 2018 Dec 17;13(12):e0206461. doi: 10.1371/journal.pone.0206461. eCollection 2018.

8.

Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy.

Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Iwata Y, Sakai N, Takamura T, Kitagawa K, Yoshimura M, Kaneko S, Yokoyama H, Wada T; Kanazawa Study Group for Renal Diseases and Hypertension.

J Diabetes Investig. 2018 Dec 5. doi: 10.1111/jdi.12981. [Epub ahead of print]

9.

Effects of 12-wk Lactobacillus plantarum OLL2712 treatment on glucose metabolism and chronic inflammation in prediabetic individuals: A single-arm pilot study.

Toshimitsu T, Gotou A, Furuichi K, Hachimura S, Asami Y.

Nutrition. 2019 Feb;58:175-180. doi: 10.1016/j.nut.2018.07.116. Epub 2018 Aug 23.

PMID:
30502681
10.

Erythropoietin signal protected human umbilical vein endothelial cells from high glucose-induced injury.

Yasuda H, Iwata Y, Nakajima S, Furuichi K, Miyake T, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Sato K, Oshima M, Yoneda-Nakagawa S, Kaneko S, Wada T.

Nephrology (Carlton). 2019 Jul;24(7):767-774. doi: 10.1111/nep.13518. Epub 2019 May 8.

PMID:
30346085
11.

Gut microbiota-derived D-serine protects against acute kidney injury.

Nakade Y, Iwata Y, Furuichi K, Mita M, Hamase K, Konno R, Miyake T, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Sato K, Oshima M, Yoneda-Nakagawa S, Yamamura Y, Kaneko S, Miyamoto T, Katane M, Homma H, Morita H, Suda W, Hattori M, Wada T.

JCI Insight. 2018 Oct 18;3(20). pii: 97957. doi: 10.1172/jci.insight.97957.

12.

Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan.

Furuichi K, Shimizu M, Hara A, Toyama T, Wada T.

Intern Med. 2018 Dec 1;57(23):3345-3350. doi: 10.2169/internalmedicine.1132-18. Epub 2018 Aug 10. Review.

13.

Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.

Oshima M, Toyama T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Hara A, Makino H, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.

PLoS One. 2018 Aug 2;13(8):e0201535. doi: 10.1371/journal.pone.0201535. eCollection 2018.

14.

Apheresis for Kidney Disease.

Furuichi K, Wada T.

Contrib Nephrol. 2018;196:188-193. doi: 10.1159/000485721. Epub 2018 Jul 24.

PMID:
30041226
15.

Clinicopathological predictors for progression of chronic kidney disease in nephrosclerosis: a biopsy-based cohort study.

Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Shimizu M, Furuichi K, Wada T.

Nephrol Dial Transplant. 2018 May 19. doi: 10.1093/ndt/gfy121. [Epub ahead of print]

PMID:
29788462
16.

Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.

Watanabe S, Saeki K, Waseda Y, Murata A, Takato H, Ichikawa Y, Yasui M, Kimura H, Hamaguchi Y, Matsushita T, Yamada K, Kawano M, Furuichi K, Wada T, Kasahara K.

J Thorac Dis. 2018 Feb;10(2):799-807. doi: 10.21037/jtd.2017.12.134.

17.

Clinico-pathological features of kidney disease in diabetic cases.

Furuichi K, Shimizu M, Okada H, Narita I, Wada T.

Clin Exp Nephrol. 2018 Oct;22(5):1046-1051. doi: 10.1007/s10157-018-1556-4. Epub 2018 Mar 21. Review.

18.

Variations of the Circle of Willis at the End of the Human Embryonic Period.

Furuichi K, Ishikawa A, Uwabe C, Makishima H, Yamada S, Takakuwa T.

Anat Rec (Hoboken). 2018 Aug;301(8):1312-1319. doi: 10.1002/ar.23794. Epub 2018 Mar 9.

PMID:
29457875
19.

A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.

Hoshino J, Furuichi K, Yamanouchi M, Mise K, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Hayami N, Suwabe T, Sawa N, Hara S, Fujii T, Ohashi K, Kitagawa K, Toyama T, Shimizu M, Takaichi K, Ubara Y, Wada T.

PLoS One. 2018 Feb 6;13(2):e0190923. doi: 10.1371/journal.pone.0190923. eCollection 2018.

20.

Successful treatment of rituximab- and steroid-resistant nephrotic syndrome with leukocytapheresis.

Takakura M, Shimizu M, Mizuta M, Inoue N, Tasaki Y, Ohta K, Furuichi K, Wada T, Yachie A.

J Clin Apher. 2018 Jun;33(3):409-411. doi: 10.1002/jca.21613. Epub 2018 Jan 16.

PMID:
29341230
21.

Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD.

Hara A, Furuichi K, Koshino A, Yasuda H, Tran TTT, Iwata Y, Sakai N, Shimizu M, Kaneko S, Nakamura H, Wada T.

Kidney Int Rep. 2017 Sep 8;3(1):133-141. doi: 10.1016/j.ekir.2017.08.017. eCollection 2018 Jan.

22.

Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.

Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Kitagawa K, Shimizu M, Furuichi K, Wada T.

PLoS One. 2018 Jan 16;13(1):e0190930. doi: 10.1371/journal.pone.0190930. eCollection 2018.

23.

Involvement of p38MAPK in Impaired Neutrophil Bactericidal Activity of Hemodialysis Patients.

Kamikawa Y, Sakai N, Miyake T, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Shimizu M, Furuichi K, Imamura R, Suda T, Kaneko S, Wada T.

Ther Apher Dial. 2018 Aug;22(4):345-354. doi: 10.1111/1744-9987.12651. Epub 2018 Jan 10.

PMID:
29318737
24.

Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis.

Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Jun;22(3):629-637. doi: 10.1007/s10157-017-1496-4. Epub 2017 Nov 11.

PMID:
29127556
25.

Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T; Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Jun;22(3):570-582. doi: 10.1007/s10157-017-1485-7. Epub 2017 Oct 27.

PMID:
29080120
26.

Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.

Wada T, Muso E, Maruyama S, Hara A, Furuichi K, Yoshimura K, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Yokoyama H, Mori N, Yuzawa Y, Matsubara T, Tsukamoto T, Wada J, Ito T, Masutani K, Tsuruya K, Fujimoto S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Kobayashi S.

Clin Exp Nephrol. 2018 Jun;22(3):591-596. doi: 10.1007/s10157-017-1488-4. Epub 2017 Oct 27.

PMID:
29080119
27.

Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.

Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development.

Clin Exp Nephrol. 2018 Apr;22(2):377-387. doi: 10.1007/s10157-017-1467-9. Epub 2017 Sep 9.

PMID:
28889347
28.

Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease.

Shinozaki Y, Furuichi K, Toyama T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Isozumi N, Nagamori S, Kanai Y, Sugiura T, Kato Y, Wada T.

Kidney Int. 2017 Dec;92(6):1356-1369. doi: 10.1016/j.kint.2017.04.032. Epub 2017 Jul 26.

PMID:
28754554
29.

Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.

Sakai N, Nakamura M, Lipson KE, Miyake T, Kamikawa Y, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Shimizu M, Furuichi K, Kaneko S, Tager AM, Wada T.

Sci Rep. 2017 Jul 14;7(1):5392. doi: 10.1038/s41598-017-05624-2.

30.

An autopsy case of vertebrobasilar dolichoectasia under hemodialysis due to autosomal dominant polycystic kidney disease.

Nakagawa S, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Matsui K, Kaneko S, Toyama T, Wada T.

CEN Case Rep. 2016 May;5(1):51-55. doi: 10.1007/s13730-015-0190-1. Epub 2015 Aug 18.

31.

Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.

Iwata Y, Satou K, Tsuzuku H, Furuichi K, Senda Y, Sakai-Takemori Y, Wada T, Fujita S, Miyake T, Yasuda H, Sakai N, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Miyagawa T, Hara A, Shimizu M, Kamikawa Y, Kaneko S, Wada T.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1839-1845. doi: 10.1007/s10096-017-2999-3. Epub 2017 May 5.

PMID:
28477235
32.

Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes.

Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T.

Nephrol Dial Transplant. 2018 Jan 1;33(1):138-148. doi: 10.1093/ndt/gfw417.

PMID:
28340221
33.

Microangiopathic antiphospholipid antibody syndrome due to anti-phosphatidylserine/prothrombin complex IgM antibody.

Senda Y, Ohta K, Yokoyama T, Shimizu M, Furuichi K, Wada T, Yachie A.

Pediatr Int. 2017 Mar;59(3):378-380. doi: 10.1111/ped.13224.

PMID:
28317300
34.

Effects of Lactobacillus plantarum Strain OLL2712 Culture Conditions on the Anti-inflammatory Activities for Murine Immune Cells and Obese and Type 2 Diabetic Mice.

Toshimitsu T, Ozaki S, Mochizuki J, Furuichi K, Asami Y.

Appl Environ Microbiol. 2017 Mar 17;83(7). pii: e03001-16. doi: 10.1128/AEM.03001-16. Print 2017 Apr 1.

35.

Epidemiology and pathogenesis of diabetic nephropathy.

Shimizu M, Furuichi K, Wada T.

Nihon Jinzo Gakkai Shi. 2017;59(2):43-49. No abstract available.

PMID:
30549912
36.

[Case of Central Venous Catheter Laceration of the Pectoralis Minor Muscle].

Endo S, Furuichi K, Morimoto K, Kotsuma Y, Yamada T, Ikenaga M, Adachi S, Ohta K, Nakashima S, Ueda M, Tsuda Y, Takayama H, Itakura H, Nishikawa K, Nishijima J.

Gan To Kagaku Ryoho. 2016 Dec;43(13):2553-2555. Japanese.

PMID:
28028264
37.

Inhibition of NLRP3 inflammasome as a therapeutic intervention in crystal-induced nephropathy.

Sakai N, Furuichi K, Wada T.

Kidney Int. 2016 Sep;90(3):466-8. doi: 10.1016/j.kint.2016.05.003.

PMID:
27521105
38.

[Clinical and pathological features of nephrosclerosis].

Furuichi K, Wada T.

Nihon Jinzo Gakkai Shi. 2016;58(2):80-4. Japanese. No abstract available.

PMID:
27169255
39.

Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.

Hara A, Furuichi K, Yamahana J, Yasuda H, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T.

J Rheumatol. 2016 Jul;43(7):1328-34. doi: 10.3899/jrheum.151430. Epub 2016 May 1.

PMID:
27134248
40.

Evidence-based clinical practice guidelines for nephrotic syndrome 2014.

Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, Kiyomoto H, Goto S, Konta T, Sasatomi Y, Sato Y, Nishino T, Tsuruya K, Furuichi K, Hoshino J, Watanabe Y, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Jun;20(3):342-70. doi: 10.1007/s10157-015-1216-x. Review. No abstract available.

41.

Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction.

Oshima M, Iwata Y, Furuichi K, Sakai N, Shimizu M, Hara A, Kitajima S, Toyama T, Shinozaki Y, Sagara A, Umeda E, Kaneko S, Arai S, Miyazaki T, Wada T.

Clin Exp Nephrol. 2017 Feb;21(1):35-42. doi: 10.1007/s10157-016-1240-5. Epub 2016 Feb 5.

PMID:
26846784
42.

Serum Autotaxin Levels Are Associated with Proteinuria and Kidney Lesions in Japanese Type 2 Diabetic Patients with Biopsy-proven Diabetic Nephropathy.

Shimizu M, Furuichi K, Toyama T, Yamahana J, Ohkawa R, Igarashi K, Aoki J, Kaneko S, Yatomi Y, Wada T.

Intern Med. 2016;55(3):215-21. doi: 10.2169/internalmedicine.55.5473. Epub 2016 Feb 1.

43.

Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis.

Kitagawa K, Furuichi K, Sagara A, Shinozaki Y, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T; Kanazawa Study Group for Renal Diseases and Hypertension.

Clin Exp Nephrol. 2016 Oct;20(5):703-711. Epub 2015 Nov 20.

PMID:
26590051
44.

Association of PAX2 and Other Gene Mutations with the Clinical Manifestations of Renal Coloboma Syndrome.

Okumura T, Furuichi K, Higashide T, Sakurai M, Hashimoto S, Shinozaki Y, Hara A, Iwata Y, Sakai N, Sugiyama K, Kaneko S, Wada T.

PLoS One. 2015 Nov 16;10(11):e0142843. doi: 10.1371/journal.pone.0142843. eCollection 2015.

45.

Calciphylaxis induced by warfarin therapy in a patient with anti-phospholipid antibody syndrome associated with systemic lupus erythematosus.

Shinozaki Y, Furuichi K, Sagara A, Kitajima S, Toyama T, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Wada T.

CEN Case Rep. 2015 Nov;4(2):169-173. doi: 10.1007/s13730-014-0161-y. Epub 2014 Dec 18.

46.

Messenger RNA expression profile of sleep-related genes in peripheral blood cells in patients with chronic kidney disease.

Kitajima S, Iwata Y, Furuichi K, Sagara A, Shinozaki Y, Toyama T, Sakai N, Shimizu M, Sakurai T, Kaneko S, Wada T.

Clin Exp Nephrol. 2016 Apr;20(2):218-25. doi: 10.1007/s10157-015-1150-y. Epub 2015 Sep 20.

PMID:
26388507
47.

Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney Function.

Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N, Perkovic V, Kobayashi M, Mano T, Kaneko S, Wada T.

PLoS One. 2015 Sep 10;10(9):e0137449. doi: 10.1371/journal.pone.0137449. eCollection 2015.

48.

Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.

Matsui K, Kamijo-Ikemori A, Imai N, Sugaya T, Yasuda T, Tatsunami S, Toyama T, Shimizu M, Furuichi K, Wada T, Shibagaki Y, Kimura K.

Clin Exp Nephrol. 2016 Apr;20(2):195-203. doi: 10.1007/s10157-015-1144-9. Epub 2015 Jul 19.

PMID:
26189083
49.

Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome.

Kuroda M, Shimizu M, Inoue N, Ikeno I, Nakagawa H, Yokoi A, Niida Y, Konishi M, Kaneda H, Igarashi N, Yamahana J, Taneichi H, Kanegane H, Ito M, Saito S, Furuichi K, Wada T, Nakagawa M, Yokoyama H, Yachie A.

Neurochem Int. 2015 Jun-Jul;85-86:24-30. doi: 10.1016/j.neuint.2015.04.003. Epub 2015 Apr 17.

PMID:
25895963
50.

[Points of revision of the guideline JSLM 2012].

Suwabe A, Maekawa M, Koshiba M, Baba H, Iinuma Y, Izuhara K, Furukawa Y, Tanaka Y, Furuichi K, Wada T, Yoshida H, Harigae H, Watanabe N, Kitajima I.

Rinsho Byori. 2014 Jul;62(7):702-9. Review. Japanese.

PMID:
25669041

Supplemental Content

Loading ...
Support Center